Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-009077

Options or other derivatives

  • COO and Secretary acquired 153,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Schuth Alexander O. COO and Secretary 2019-02-07 Grant or award · Restricted Stock Units +17,000 17,000 D
Schuth Alexander O. COO and Secretary 2019-02-07 Grant or award · Stock Option (right to buy) +136,000 136,000 D
Loading xslF345X03/doc4.xml…